| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0013232> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0013264> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0029308> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0162692> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0162693> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0162694> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0162695> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0162696> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0678236> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0917713> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C0920627> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C3542021> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35034352_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Critical Path Institute, Tucson, Arizona, USA.\', \'Center for Innovation in Brain Sciences, University of Arizona Health Sciences, Tucson, Arizona, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Barrett_Jeffrey> <https://research.tib.eu/covid-19/entity/Brinton_Roberta> <https://research.tib.eu/covid-19/entity/Ollivier_Cecile> <https://research.tib.eu/covid-19/entity/Stephenson_Diane>
?:doi	10.1002/cpt.2528
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/cpt.2528>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Clinical pharmacology and therapeutics
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35034352>
?:pmid	<https://research.tib.eu/covid-19/entity/35034352>
?:pmid	35034352
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.699
?:rankingScore_hIndex	169
?:title	Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35034352>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35034352>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all